Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Sarcoma, Ewing 1Pain 1Osteosarcoma 1Osteonecrosis 1Nasopharyngeal Carcinoma 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphedema 1Leukemia 1Hodgkin Disease 1Exostoses, Multiple Hereditary 1Deglutition Disorders 1Colonic Neoplasms 1Chondrosarcoma 1Breast Neoplasms 1Bone Neoplasms 1Anemia, Sickle Cell 1

Interventions

Cisplatin 104Radiotherapy, Intensity-Modulated 59Gemcitabine 53toripalimab 35Fluorouracil 30Docetaxel 30Capecitabine 28Radiotherapy 23Drug Therapy 20camrelizumab 19nimotuzumab 16nedaplatin 12Chemoradiotherapy 12sintilimab 11apatinib 11Induction Chemotherapy 11Immune Checkpoint Inhibitors 11spartalizumab 10endostar protein 8Paclitaxel 8Cetuximab 8tislelizumab 7pembrolizumab 7Endostatins 7Bevacizumab 7anlotinib 6Radiation 6Endoscopy 6fludarabine 5S 1 (combination) 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Carcinoma × Range of Motion, Articular × Clear all
NCT00815087 2014-03-26

Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)

National Taiwan University Hospital

Phase 2 Completed
20 enrolled 6 charts
Head & Neck

Nasopharyngeal Carcinoma, Deglutition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡